F13.150 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions

Name of the Condition

• Sedative, Hypnotic, or Anxiolytic Abuse with Sedative, Hypnotic or Anxiolytic-Induced Psychotic Disorder with Delusions (ICD-10 Code: F13.150)

Summary

This condition involves the misuse of sedative, hypnotic, or anxiolytic substances, such as benzodiazepines or barbiturates, leading to a substance-induced psychotic disorder characterized by delusions. It is marked by a pattern of use that causes clinically significant impairment, including psychotic symptoms like fixed false beliefs, alongside the behavioral and physiological effects of abuse.

Causes

The condition arises from the non-medical use of sedative, hypnotic, or anxiolytic drugs, often initiated for recreational purposes or self-medication. Prolonged or high-dose use can disrupt neurotransmitter systems, triggering psychotic symptoms, including delusions, in susceptible individuals.

Risk Factors

• A history of substance abuse or dependence on sedative, hypnotic, or anxiolytic drugs.
• Co-occurring mental health conditions, such as anxiety, depression, or prior psychotic disorders.
• Chronic stress or exposure to environments where substance use is normalized.
• Genetic predispositions or personal/family history of psychotic disorders.

Symptoms

• Use of sedative, hypnotic, or anxiolytic substances in larger amounts or for longer durations than intended.
• Persistent desire or unsuccessful attempts to cut down or control use.
• Significant time spent obtaining, using, or recovering from the substance.
• Continued use despite social, occupational, or interpersonal problems caused by use.
• Delusions (fixed false beliefs) that are substance-induced and not better explained by another condition.
• Other psychotic symptoms, such as hallucinations or disorganized thinking, may also occur.

Diagnosis

Diagnosis requires a clinical evaluation, including a detailed patient history and assessment of substance use patterns. Delusions must be directly attributable to the sedative, hypnotic, or anxiolytic use, with symptoms developing during or shortly after intoxication or withdrawal. Ruling out other causes of psychosis, such as primary mental disorders, is essential.

Treatment Options

Treatment focuses on discontinuing the substance, managing withdrawal, and addressing psychotic symptoms. Interventions may include:

• Medically supervised detoxification to ensure safety.
• Antipsychotic medications to alleviate delusions or hallucinations.
• Psychotherapy, such as cognitive-behavioral therapy, to address substance use and psychotic symptoms.
• Supportive care, including monitoring for co-occurring conditions.

Prognosis and Follow-Up

Prognosis depends on the severity of substance use and psychotic symptoms, as well as adherence to treatment. Early intervention and sustained abstinence improve outcomes. Follow-up care is critical to monitor for relapse, manage residual symptoms, and address co-occurring disorders.

Complications

• Worsening of psychotic symptoms, including persistent delusions.
• Increased risk of accidents or injuries due to impaired judgment.
• Development of substance dependence or other substance use disorders.
• Social or occupational dysfunction, including relationship problems or job loss.
• Potential for overdose or life-threatening withdrawal complications.

Lifestyle & Prevention

• Avoid non-medical use of sedative, hypnotic, or anxiolytic drugs.
• Follow prescribed dosages and durations strictly under medical supervision.
• Seek help for stress, anxiety, or sleep issues to reduce self-medication risks.
• Engage in healthy coping strategies, such as exercise or therapy, to manage triggers.
• Maintain open communication with healthcare providers about substance use concerns.

When to Seek Professional Help

Seek immediate medical attention if experiencing:

• Intense delusions or hallucinations that disrupt daily functioning.
• Severe withdrawal symptoms, such as seizures or extreme agitation.
• Thoughts of self-harm or harm to others.
• Inability to stop using the substance despite negative consequences.

Tips for Medical Coders

Document the presence of sedative, hypnotic, or anxiolytic abuse and the specific psychotic disorder with delusions. Ensure clinical notes support the temporal relationship between substance use and psychotic symptoms. Code F13.150 is appropriate when delusions are the primary substance-induced psychotic feature, and no other psychotic disorders are present.